CorMedix shareholders approve stock plan amendment increasing authorized shares; all director nominees elected

CorMedix Inc.

Plan amendment to increase share authorization under 2019 Omnibus Stock Incentive Plan approved with 16.5M FOR, 2.8M AGAINST, 0.8M abstain.
All 7 director nominees elected: Dillione, Duncan, Dunton, Kaplan, Lefkowitz, Stewart, Todisco – each received >15.8M FOR votes.
Non-binding advisory vote on 2023 executive compensation passed (FOR: 17.5M, AGAINST: 2.4M).
Ratification of Marcum LLP as auditor for FY2024 approved with 40.5M FOR, 215K against, 370K abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.